Markets opened lower this morning but managed to recover fairly quickly following a report on robust manufacturing growth (our coverage here). The report on construction spending came in weaker than expected (our…
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) this morning announced that its colorectal cancer treatment did no better than placebo in a Phase 3 trial. The company said it will evaluate whether or not…
Paul Ausick After opening lower this morning on weak data from Europe and Asia, the ISM non-manufacturing index for the US came in better than expected, but it was not enough to swing indexes…
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are many…
Yesterday was a Cluster-something or an outright debacle. The stock market was a sea of red, but outside of inverse-ETF products there were actually many winners. We tried to look for the…
There are more recognized stocks in today’s edition of the BioHealth Business Daily. We are seeing significant and unusual moves, or implications, in shares of Celgene Corporation (NASDAQ: CELG), DUSA Pharmaceuticals, Inc.…
Twitter has, by most estimates, 75 million visitors a month, which makes it one of the largest social networks in the world. All major media companies are on Twitter and some have…
Today’s version of the BioHealth Business Daily includes some less covered stocks because of the impact from the news flow today. We are seeing shares moving in Aeterna Zentaris Inc. (NASDAQ: AEZS),…
These are Monday’s top day trader and active trader alerts seen in the pre-market levels. We have a link to each story where applicable over at VSInvestor.com with more details and analysis:…
These are this Wednesday morning’s top pre-market day trader alert and active trader alert stocks moving on unusual trading volume. We have a link through to more color and analysis on price…
Lehman (NYSE: LEH) hit by concerns about huge Q1 write-offs. Falls to $42.77 from 52-week high of $82.05. Citigroup (NYSE: C) sells off because bank may have to raise more money. Down…
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) may have just joined the ranks of a biotech zombie, even if it doesn’t want to admit that. The company announced that top-line results from its SUN-MICRO…
Douglas A. McIntyre These are some of the analyst calls that 247WallSt.com is focusing on in early pre-market trading this Monday morning: Aeropostale (NYSE: ARO) Cut To Sell From Hold at Citigroup. AbitibiBowater (NYSE: ABH)…
Stock Tickers: ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON The DJIA & S&P 500 Index may have put in new highs today, but as you know there are always…
(AA) An ALCOA bid from BHP may be kindled according to numerous M&A reports.(ADVNA) Advanta trades ex-split to reflect a 3-2 stock split.(AGU) Agrium said earnings will be at or above the…
